diabetestalk.net

Type 2 Diabetes And Comorbid Symptoms Of Depression And Anxiety: Longitudinal Associations With Mortality Risk

Type 2 Diabetes and Comorbid Symptoms of Depression and Anxiety: Longitudinal Associations With Mortality Risk

Type 2 Diabetes and Comorbid Symptoms of Depression and Anxiety: Longitudinal Associations With Mortality Risk

OBJECTIVE Depression is strongly linked to increased mortality in individuals with type 2 diabetes. Despite high rates of co-occurring anxiety and depression, the risk of death associated with comorbid anxiety in individuals with type 2 diabetes is poorly understood. This study documented the excess mortality risk associated with symptoms of depression and/or anxiety comorbid with type 2 diabetes.
RESEARCH DESIGN AND METHODS Using data for 64,177 Norwegian adults from the second wave of the Nord-Trøndelag Health Study (HUNT2), with linkage to the Norwegian Causes of Death Registry, we assessed all-cause mortality from survey participation in 1995 through to 2013. We used Cox proportional hazards models to examine mortality risk over 18 years associated with type 2 diabetes status and the presence of comorbid affective symptoms at baseline.
RESULTS Three clear patterns emerged from our findings. First, mortality risk in individuals with diabetes increased in the presence of depression or anxiety, or both. Second, mortality risk was lowest for symptoms of anxiety, higher for comorbid depression-anxiety, and highest for depression. Lastly, excess mortality risk associated with depression and anxiety was observed in men with diabetes but not in women. The highest risk of death was observed in men with diabetes and symptoms of depression only (hazard ratio 3.47, 95% CI 1.96, 6.14).
CONCLUSIONS This study provides evidence that symptoms of anxiety affect mortality risk in individuals with type 2 diabetes independently of symptoms of depression, in addition to attenuating the rel Continue reading

Rate this article
Total 1 ratings
40% of American adults will develop type 2 diabetes in their lifetime

40% of American adults will develop type 2 diabetes in their lifetime

In the US, 2 in every 5 adults are expected to develop type 2 diabetes throughout their lifetime. This is according to a new study published in The Lancet Diabetes & Endocrinology.
Type 2 diabetes accounts for 90-95% of all diabetes cases in the US. Onset occurs when the body does not produce enough insulin, or the insulin that is produced does not function properly, causing abnormal blood glucose levels.
Diabetes prevalence has increased in recent years. In 2010, 25.8 million Americans had the condition, and this rose to 29.1 million by 2012.
However, the research team - led by Dr. Edward Gregg, chief of the Epidemiology and Statistics Branch, Division of Diabetes Translation at the Centers for Disease Control and Prevention (CDC) - notes that the mortality rate in US populations with and without diabetes has declined.
"The simultaneous changes in incidence and mortality warrant re-examination of lifetime risk of diabetes and life-years lost due to diabetes," say the researchers.
Lifetime risk of type 2 diabetes rises to 40% over 26 years
With this in mind, Dr. Gregg and colleagues analyzed data from the National Health Interview Survey (NHIS), which disclosed diabetes incidence in the US from 1985 to 2011. In addition, they assessed the death certificates of 598,216 adults.
All information was used to estimate the lifetime risk of diabetes in the US, as well as years of life lost to the condition.
The team found that for an average 20-year-old American, the lifetime risk of developing type 2 diabetes increased from 20% in 1985-89 to 40% in 2000-11 for men, while lifetime Continue reading

Maternal obesity as a risk factor for early childhood type 1 diabetes: a nationwide, prospective, population-based case–control study

Maternal obesity as a risk factor for early childhood type 1 diabetes: a nationwide, prospective, population-based case–control study

Abstract
Genetic and environmental factors are believed to cause type 1 diabetes. The aim of this study was to investigate the influence of maternal BMI and gestational weight gain on the subsequent risk of childhood type 1 diabetes.
Children in the Swedish National Quality Register for Diabetes in Children were matched with control children from the Swedish Medical Birth Register. Children were included whose mothers had data available on BMI in early pregnancy and gestational weight gain, giving a total of 16,179 individuals: 3231 children with type 1 diabetes and 12,948 control children.
Mothers of children with type 1 diabetes were more likely to be obese (9% [n = 292/3231] vs 7.7% [n = 991/12,948]; p = 0.02) and/or have diabetes themselves (2.8% [n = 90/3231] vs 0.8% [n = 108/12,948]; p < 0.001) compared with mothers of control children. Gestational weight gain did not differ significantly between the two groups of mothers. In mothers without diabetes, maternal obesity was a significant risk factor for type 1 diabetes in the offspring (p = 0.04). A child had an increased risk of developing type 1 diabetes if the mother had been obese in early pregnancy (crude OR 1.20; 95% CI 1.05, 1.38; adjusted OR 1.18; 95% CI 1.02, 1.36). Among children with type 1 diabetes (n = 3231) there was a difference (p < 0.001) in age at onset in relation to the mother’s BMI. Among children in the oldest age group (15–19 years), there were more mothers who had been underweight during pregnancy, while in the youngest age group (0–4 years) the pattern was reversed.
Maternal obesity, in th Continue reading

Drinking red wine regularly reduces risk of diabetes

Drinking red wine regularly reduces risk of diabetes

Drinking red wine three to four times a week lowers the risk of developing type 2 diabetes according to a recent study by Danish researchers.
The study, carried out on over 70,000 people over five years, was published in Diabetologia and monitored how much and how often they drank.
The results found that drinking moderately three to four times a week reduced a woman’s risk of type 2 diabetes by 32%, while it lowered a man’s risk by 27%.
Red wine was found to be particularly beneficial to lowering the risk of developing diabetes because the polyphenols in red wine help to manage blood sugar levels, according to the study.
Men who drink one to six beers a week lowered their risk of diabetes by 21% but there was no impact on women’s risk.
Meanwhile, a high intake of spirits among women significantly increased their risk of diabetes, while there was no effect in men.
Experts warned that the results shouldn’t be treated as a “green light” to drink in excess of the existing NHS guidelines – 14 units of alcohol a week.
“We found that drinking frequency has an independent effect from the amount of alcohol taken.
“It’s better to drink the alcohol in four portions rather than all at once,” said Prof Janne Tolstrup, from the National Institute of Public Health of the University of Southern Denmark.
The study also found that drinking moderately a few times a week lowered the risk of cardiovascular disorders, such as heart attacks and strokes. Continue reading

Cheers! For those managing diabetes, wine can help, study says

Cheers! For those managing diabetes, wine can help, study says

(Lawrence K. Ho / Los Angeles Times)
People with Type 2 diabetes get an earful of grim lectures about their health prospects and endure much hardship to manage their condition well. But new research offers those who do so a rare reward. A glass of wine every day not only won't hurt, says a new study: It can actually improve cardiac health, help manage cholesterol and foster better sleep.
The new research, published Monday in the Annals of Internal Medicine, found that compared with a nightly glass of mineral water, a single glass of wine--red or white--offered those with well-managed Type 2 diabetes some benefits.
After two years, those who drank a glass of white wine nightly improved their triglyceride levels compared with those who drank water or red wine.
See the most-read stories in Science this hour >>
But red wine's benefits were far more numerous and more pronounced than those of white wine: Ruby-colored varietals significantly increased participants' HDL cholesterol--the "good" form of cholesterol that protects against heart disease--by nearly 10% and improved the overall cholesterol profiles of those who got it. Red wine drinkers also saw improvements in their apolipoprotein a1 levels--a measure of lipid metabolism.
Compared with study participants who drank mineral water nightly and those who had a glass of white wine, diabetics who drank a glass of red wine nightly also had fewer symptoms of metabolic syndrome (hypertension, excess abdominal fat, high blood sugar and abnormal cholesterol levels) at the end of two years.
In people without disease, many studies hav Continue reading

No more pages to load

Popular Articles

Related Articles